Announced
Completed
Financials
Sources
Tags
Malaysia
pharmaceuticals
Pharmaceuticals
Acquisition
Domestic
Single Bidder
Private
Majority
Private Equity
Completed
Friendly
Synopsis
Ekuinas, a private equity fund management company, completed the acquisition of a 80% stake in Symbiotica, a pharma ingredients producer. Financial terms were not disclosed. “Having achieved progressive and consistent growth over the past two decades, and being a well-regulated and certified API supplier, Symbiotica, as one of the largest API manufacturers in SEA, is well-positioned to take advantage of the macro trends driving this sector’s future growth," Datuk Syed Yasir Arafat Syed Abd Kadir, Ekuinas CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.